- < Prev
1 of 1
- Next >
Feb 24, 2014, 08:00 ET
Novartis announced today that its meningococcal serogroup B (MenB) vaccine, Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]), will be used as part of a vaccination program at the University of California Santa Barbara (UCSB) that began today and will end on March 7....
More news about: Novartis
Feb 17, 2014, 06:30 ET
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. ("CoStim") has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is...
Feb 13, 2014, 06:00 ET
GenVec, Inc. (NASDAQ: GNVC) today announced that the company has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders. In January 2014, Novartis filed an Investigational New Drug (IND) application with the...
Feb 09, 2014, 05:00 ET
INTERNATIONAL photographer and artist Anne Geddes invites us to take a fresh look at disability, with three new thought-provoking portraits of UK children who have lost limbs to meningitis. (Photo: http://photos.prnewswire.com/prnh/20140209/668113-a...
More news about: Novartis Vaccines and Diagnostics
Jan 15, 2014, 16:37 ET
McGraw Hill Construction's Architectural Record (http://www.ArchitecturalRecord.com), part of McGraw Hill Financial (NYSE: MHFI), today announced the firms it is honoring with the third annual "Good Design is Good Business" Lifetime Achievement Awards. The...
Jan 13, 2014, 01:30 ET
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has reached an agreement with Novartis to reacquire rights to two anti-cancer compounds -- pixantrone (PIXUVRI®) and paclitaxel poliglumex (Opaxio™). Under the terms of the previous agreement, CTI has been...
Jan 08, 2014, 18:50 ET
Patient safety and well-being are the highest priority at Novartis Pharmaceuticals Corporation (NPC). NPC is dedicated to improving patient health and supports patient medication adherence programs integral to this goal. These include outreach by pharmacies aimed at helping patients...
More news about: Novartis Pharmaceuticals Corporation
- < Prev
1 of 1
- Next >